Volume 58, Issue 6, Pages (June 2013)

Presentación del tema: "Volume 58, Issue 6, Pages (June 2013)"— Transcripción de la presentación:

1 Volume 58, Issue 6, Pages 1104-1112 (June 2013)
Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus  Juan Berenguer, Julio Alvarez-Pellicer, Ana Carrero, Miguel A. Von Wichmann, José López-Aldeguer, Josep Mallolas, María J. Galindo, Eva Van Den Eynde, María J. Téllez, Carmen Quereda, Cristina Tural, José Sanz, Carlos Barros, Ignacio Santos, Federico Pulido, Josep M. Guardiola, Enrique Ortega, Rafael Rubio, Juan J. Jusdado, María L. Montes, Gabriel Gaspar, Elena Barquilla, José M. Bellón, Juan González-García  Journal of Hepatology  Volume 58, Issue 6, Pages (June 2013) DOI: /j.jhep Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

2 Fig. 1 Proportion of patients free from events. (A) Overall mortality, (B) liver-related events (liver-related mortality, liver decompensation, hepatocellular carcinoma, liver transplantation) according to treatment response, (C) liver decompensation, and (D) hepatocellular carcinoma. ∗p <0.05 with the NR group (Log-Rank test); †p <0.05 with the REL group (Log-Rank test). SVR, Sustained virologic response; REL, end-of-treatment response with subsequent relapse; NR, no response. Journal of Hepatology  , DOI: ( /j.jhep ) Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

3 Fig. 2 Liver stiffness following interferon plus ribavirin. Last transient elastography results according to treatment responses in patients with (A) baseline liver fibrosis with F0–F2, and (B) baseline liver fibrosis with F3–F4. NR, no response; REL, end-of-treatment response with subsequent relapse; SVR, sustained viral response; IQR, interquartile range; Δt (months) to last TE, time (months) from the date interferon plus ribavirin was stopped to last transient elastography measurement. ∗p=0.98 for differences between the 3 groups; †p=0.47 for differences between the 3 groups; #p <0.05 in comparison with NR; ‡p <0.05 in comparison with REL. Journal of Hepatology  , DOI: ( /j.jhep ) Copyright © 2013 European Association for the Study of the Liver Terms and Conditions